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Trypanosoma cruzi, the causative agent of human Chagas disease, is endemic to the southern region of the United States where it routinely infects many host species. The indoor/outdoor housing configuration used in many non-human primate research and breeding
facilities in the southern of the USA provides the opportunity for infection by T. cruzi and
thus provides source material for in-depth investigation of host and parasite dynamics in a
natural host species under highly controlled and restricted conditions. For cynomolgus
macaques housed at such a facility, we used a combination of serial blood quantitative PCR
(qPCR) and hemoculture to confirm infection in >92% of seropositive animals, although
each method alone failed to detect infection in >20% of cases. Parasite isolates obtained
from 43 of the 64 seropositive macaques were of 2 broad genetic types (discrete typing
units, (DTU’s) I and IV); both within and between these DTU groupings, isolates displayed a
wide variation in growth characteristics and virulence, elicited host immune responses, and
susceptibility to drug treatment in a mouse model. Likewise, the macaques displayed a
diversity in T cell and antibody response profiles that rarely correlated with parasite DTU
type, minimum length of infection, or age of the primate. This study reveals the complexity of
infection dynamics, parasite phenotypes, and immune response patterns that can occur in a
primate group, despite being housed in a uniform environment at a single location, and the
limited time period over which the T. cruzi infections were established.

Author summary
We evaluated naturally occurring infections of Trypanosoma cruzi, the causative agent of
human Chagas disease, in an indoor/outdoor primate colony at a breeding facility in
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Parasitology and immunology of T. cruzi infection in a NHP colony

Texas, USA. Using serial quantitative PCR and hemoculture, we confirmed infection in
92% of the 64 seropositive animals, but neither of these two methods confirmed more
than 80% of the cases. Parasites by hemoculture fell into two genetic groups (discrete
typing units I and IV), and displayed large variation in growth characteristics, elicited cellular and humoral immune responses as well as virulence and drug susceptibility when
tested in mice. EKG abnormalities were found in 13 out of 51 qPCR-positive macaques.
Our results demonstrate the complexity of these infection parameters in this colony
in spite of the uniform and geographically constrained housing conditions of the
macaques.

Introduction
Trypanosoma cruzi is the agent of human Chagas disease, the highest impact parasitic disease
in the Americas, affecting 10–20 million individuals. Although T. cruzi infection has been
studied for over a century in its numerous mammalian hosts, including humans, there remain
many unanswered questions and misconceptions concerning the factors that determine the
control of the infection and the progression and severity of, and the tissues affected by, the disease. Irrespective of the host species, T. cruzi is nearly always a persistent infection and disease
development is progressive in the absence of effective treatment. Although such treatments
exist, few individuals benefit from them for a variety of reasons, including the justifiable concerns of side effects, the documented failure in some cases to cure the infection and the shortage of drugs [1–4]. The misconceptions surrounding T. cruzi infection and Chagas disease
emanate in part from the largely anecdotal nature of investigations of human infections, the
remarkable genetic variability among individual isolates of T. cruzi, and the limited number of
these genetic variants that have been extensively studied in naturally infected hosts, especially
humans.
Natural transmission of T. cruzi in humans and domestic animals remains a significant
problem in many countries in Latin America and is a growing concern in the southern United
States of America [5–7]. T. cruzi and insect species that can vector the infection have likely
been present in the USA for at least thousands of years [8] and occasional transmission to
humans living exclusively in the USA has been documented [9–12]. In contrast to humans,
domestic and other animals are quite frequently reported to acquire T. cruzi infection, almost
certainly via infected insect vectors [13–17]. Included among the animals known to be commonly infected with T. cruzi in the USA are non-human primates maintained in breeding and
research colonies and in zoological settings. The identification of a large cohort of cynomolgus
macaques (Macaca fascicularis) with naturally acquired T. cruzi infection at the Southwest
National Primate Research Center (SNPRC) provided a unique opportunity to study, in a relatively large primate population, the parasitological and immunological parameters associated
with the infection and disease.
Herein we report results obtained from a large colony of primate hosts infected with T.
cruzi via natural environmental exposure and provide the first comprehensive immunological
and pathological analysis in conjunction with genotypic and phenotypic characterization of
the parasites isolated from these hosts. The study reveals multiple genotypes and a very broad
range of phenotypes among parasites isolated from hosts infected in a single, clustered set of
housing units. However, the data revealed no association between specific patterns of host
immune responses or disease with specific parasite genotypes or phenotypes.
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Results
Study group
Previous studies documented T. cruzi infection among non-human primates housed in outdoor enclosures at the SNPRC where they may have acquired the infection by ingesting
infected insects [18,19]. In this study, 64 cynomolgus macaques (Macaca fascicularis) of both
sexes with positive conventional serology for T. cruzi infection were studied. The average age
of the animals was 12 years (range 7–22 years) and they were estimated to have been infected a
minimum average of approximately 6.4 years (range 1.5–8.5 years; S1 Fig).

qPCR and hemoculture of serial blood samples failed to detect infection in
all seropositive macaques
qPCR was performed on blood samples from the 64 seropositive macaques on up to three different time points over a 3-month period during the spring-summer seasons. This serial qPCR
approach yielded a positive result in at least one sample for 51 animals (80%). Out of the 61
animals sampled at least twice, 26 had both samples positive and 22 had only one sample positive. Testing for a third time confirmed the PCR positive result in 7 of 16 animals and detected
T. cruzi DNA in the blood of 2 of the 13 animals previously testing negative. Cumulatively, for
PCR positive animals screened more than once, 83 of those 129 tests (64%) were positive.
For further detection of infection and isolation of parasites from the animals, the red blood cell
fraction of whole blood (after the isolation of peripheral blood mononuclear cells (PBMCs) over
Ficoll) was cultured and resulted in detectable parasite growth and further cultivation of T. cruzi
isolates from 43 of the seropositive animals (67%). Qualitative PCR of the hemocultures that
lacked visible parasite growth identified 8 additional T. cruzi positive hemocultures, bringing the
overall detection level for the hemoculture technique to 51 out of 64 samples (80%). Notably, 8 of
the 13 consistently qPCR negative, seropositive animals yielded a positive hemoculture with the
isolation of viable parasites. The combination of serial qPCR and hemoculture/PCR confirmed T.
cruzi infection in a total of 59 out of 64 seropositive macaques (92%; Fig 1A). Not surprisingly,
blood samples that yielded a positive hemoculture/PCR had on average a higher parasite equivalent per ml value in the qPCR than those that were negative by hemoculture (Fig 1B).

T. cruzi-infected macaques display robust T cell and antibody responses
To further assess the strength and breadth of the antibody responses to T. cruzi in these
macaques, plasma samples were screened against a panel of 9 recombinant T. cruzi proteins as
well as a trypomastigote/amastigote lysate using a bead-based multiplex platform [20,21]. All
the macaques had high levels of IgG antibodies reactive with the T. cruzi lysate which modestly
correlated (rs = 0.26; p = 0.04) with parasite loads in blood as determined by qPCR (Fig 2A).
As previously demonstrated in humans [20,21] and canines [22] each animal had a distinct
profile of antibodies against the antigen panel (Fig 2B). The most frequently detected proteins
were the 60S acidic ribosomal subunit protein and a TolT surface protein which were recognized by 77% and 55% of the macaques, respectively (Fig 2C).
All the infected macaques exhibited IFN-gamma-producing cells in response to a parasite
lysate and the frequency of responding T cells correlated with their respective antibody
responses (Fig 3A) but not with the parasite load (as determined by qPCR; Fig 3B). T cell
responses to a pool of macaque CMV peptides were also monitored to assess overall immune
competence (as in humans, CMV infection is common in these primates). Although macaque
samples displayed a wide range of T cell responsiveness to the CMV peptides, this response
did not correlate with the cellular response against T. cruzi lysate, suggesting that there was not
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Fig 1. Serial qPCR and hemoculture confirmed T. cruzi infection in 92% of seropositive macaques. (A) Study
group. Peripheral blood samples from 64 macaques positive for T. cruzi infection by conventional serology were
screened by serial qPCR and hemoculture performed as described in Materials and Methods. Serologically positive
macaques were confirmed by blood qPCR (qPCR), visible parasites in hemocultures (Hemoculture) and by qualitative
PCR in hemocultures without visible parasites (culture/PCR). (B) Parasite load in blood determined by serial qPCR
versus presence or absence of parasite growth in macaque hemocultures. Hemocultures designated positive (Hem+)
showed parasite growth or qualitative PCR+ in the culture. Blood samples were analyzed by qPCR at up to three time
points, and the mean value of T. cruzi equivalents per ml in all the samples for each individual macaque was calculated.
Each symbol represents an individual macaque (n = 64). � indicates P<0.05 as determined by Mann Whitney test.
https://doi.org/10.1371/journal.pntd.0009141.g001

an immunosuppressive effect induced by either T. cruzi or CMV that influenced cellular
immune responses in general (Fig 3C).
In human T. cruzi infection, the intensity and quality of anti-parasite T cell responses
decrease with the apparent length of infection in a phenomenon described as T cell exhaustion
[23]. However, in this group of infected macaques, a correlation between the strength of the
cellular (Fig 4A) or antibody (Fig 4B and 4C) response with the duration of infection was not
evident. Similarly, there was not a clear relationship between parasite load in blood by qPCR
and the minimum length of the infection (Fig 4D).
Collectively, these immunological analyses document that humoral and cellular immune
responses were detected in all study subjects, but that these responses vary greatly in strength
and breadth. However, these differences do not appear related to the minimum length of infection and only the antibody response to a T. cruzi lysate correlated with the apparent parasite
load as assessed by blood qPCR.

T. cruzi infected macaques display low levels of early differentiated
(CD45RA-CD27+CD28+) and high levels of late differentiated
(CD45RA-CD27-CD28-) memory CD8+ T cells
Chronically chagasic patients have been documented to have altered T cell populations
consistent with long-term stimulation due to persistent infection [24]. To determine if similar
alterations in the overall peripheral T cell populations were present in nonhuman primates
with long-term T. cruzi infections, we analyzed the different lymphocyte populations in
peripheral blood samples of infected animals and compared them with a small group of seronegative macaques from the same colony. Infected animals displayed on average a slightly
higher proportion of T effector memory cells (CD28-CD95+) and a lower proportion of
naive T cells (CD28+CD95-) relative to non-infected controls in both the CD8+ and CD4+
populations (Fig 5A). Infected animals also displayed a higher proportion of fully differentiated memory (CD45RA-CD27-CD28-) and lower levels of early differentiated memory
(CD45RA-CD27+CD28+) CD8+ T cells than non-infected macaques (Fig 5B). A higher
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Fig 2. T. cruzi infected macaques display high levels of specific antibodies against parasite antigens. (A) Reactivity of macaque sera against T. cruzi
lysate is displayed on the X-axis as median fluorescence intensity (MFI) in a multiplex assay and related on the Y-axis to mean parasite load in blood
determined by serial qPCR. Each symbol represents an individual macaque (n = 64). (B) Reactivity against 9 recombinant T. cruzi proteins. Each bar
represents the median fluorescence intensity (MFI) to the specific antigen. Individual macaques are referred by their identification number on the X axes
and the genotype of the parasites isolated from that macaque are noted. T. cruzi lysate and green fluorescent protein (GFP) were used as positive and
negative controls respectively. Graphs are representative of macaques with weak (top), intermediate (middle), and strong (bottom) reactivity against the
recombinant proteins. ND: no parasites were obtained by hemoculture to allow genotyping. (C) Percentage of macaques with a median fluorescence
intensity above the negative control (GFP) for each T. cruzi recombinant protein. rs: Spearman’s correlation coefficient; � p<0.05.
https://doi.org/10.1371/journal.pntd.0009141.g002

proportion of fully differentiated memory CD4+ T cells was also evident in the infected animals. Thus, the phenotype of the T cell populations reflects T. cruzi infection status of the
macaques.

Parasite isolates from infected macaques exhibit significant genetic and
phenotypic variation
Genetic characterization of T. cruzi isolates from the macaques showed two of the possible 6
genetic lineages previously described in T. cruzi [25], TcI and TcIV, with a higher proportion of
the former. A genetic pattern corresponding to a mixed infection of both lineages was clearly
evident in one animal (Fig 6A). On average, macaques infected with parasites of the TcIV lineage displayed a slightly higher cellular and antibody response against T. cruzi lysate (Fig 6B and
6C) although there were no differences in the parasite levels in blood or in the duration of infection between the groups of macaques infected with one or the other lineage (S2 Fig). Parasite
lineage also did not track with the diversity or strength of antibody responses (Fig 2B).
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Fig 3. Infected macaques display a variable T cell response against T. cruzi lysate. (A) Peripheral blood
mononuclear cells (PBMC) from seropositive macaques were stimulated overnight with T. cruzi lysate and the IFNg
response was measured by ELISpot. (A) Cellular and antibody response against T. cruzi lysate for individual macaques.
(B) Cellular response against T. cruzi lysate plotted against the parasite load in blood determined by serial qPCR. (C)
The cellular response against T. cruzi lysate was compared to the cellular response against cytomegalovirus peptides
measured by ELISpot on PBMCs from the same blood sample of individual macaques. rs: Spearman’s correlation
coefficient; � p<0.05. (n = 64).
https://doi.org/10.1371/journal.pntd.0009141.g003

To further explore the range of phenotypes in parasites isolated from animals naturally
infected in this single housing complex, we infected both C57BL/6J wild-type (WT) and mice
genetically deficient in interferon-γ production (IFNγ-KO) with subsets of the isolates. All of
these isolates converted from epimastigotes into infective metacyclic trypomastigotes in triatomine artificial urine (TAU) media and all successfully established infections in mice. All WT
mice survived acute infection with 106 metacyclic trypomastigotes from 8 isolates, and maintained persistent infections as demonstrated by the detection of T. cruzi microsatellite DNA at
a range of levels in skeletal muscle, cardiac muscle, and adipose tissues at 120–150 days postinfection (dpi; Fig 7A). Infections in IFN-γ KO mice revealed a wide range of infection intensity among the isolates from macaques (Fig 7B). The majority of the IFN-γ KO mice succumbed to infection by 21 days, however mice infected with some of the isolates survived to
~60 dpi, and IFN-γ KO mice infected with isolate 20392 survived > 90 dpi.
We also measured the ability of isolates to induce peripheral blood CD8+ T cells specific for
the immunodominant CD8+ T cell epitope TSKb20, a response we had previously shown to
vary depending on the infecting parasite strain [26]. Fig 7C shows that all isolates tested elicited TSKb20-specific T cells although the frequencies observed at 4 weeks post-infection ranged widely.
Lastly, to assess the susceptibility of the isolates to benznidazole (BNZ) treatment, C57BL/6J
WT mice were infected, BNZ-treated beginning at ~30 dpi and then immunosuppressed with
cyclophosphamide to determine the effectiveness of treatment, as previously described [27]. In
11 of the 16 isolates, BNZ treatment resulted in 100% cure (Fig 7D). However, mice infected
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Fig 4. Minimum length of infection in macaques does not modify immunological and parasitological parameters.
Cellular (A) and humoral (C) responses against T. cruzi lysate for macaques displaying diverse minimum lengths of
infection. (B) Number of recombinant T. cruzi antigens recognized by macaques infected for different periods of time
measured by multiplex assay. (D) Parasite load in macaque blood determined by serial qPCR. (n = 50).
https://doi.org/10.1371/journal.pntd.0009141.g004

with isolates 20202, 20288, 20290, 20349, or 20566 showed a number of treatment failures,
similar to what has been reported with other more “benznidazole-resistant” T. cruzi lines [27].

A proportion of infected macaques displayed EKG abnormalities and a
poor health status
The 51 qPCR positive macaques were screened for EKG abnormalities and 26% had at least
one detectable abnormality with 3 animals displaying 2 different abnormalities (Table 1). The
most prevalent cardiac problems were: left anterior fascicular block, sinus bradycardia and
complete right bundle branch block. Notably, these same abnormalities are common in
human chagasic heart disease [28, 29]. There was no association between parasitological or
immunological parameters and the presence of disease (Table 1). Additionally, a small proportion of the animals with a normal EKG profile displayed other health conditions (e.g. heart
murmur or “dull sounds”). When clustered in three different groups: no symptoms, poor
health and cardiac abnormality (Fig 8), the group of macaques with cardiac problems showed
significantly higher antibody responses to T. cruzi lysate compared to the group without evident symptoms, while this trend was not statistically significant for the cellular immune
response. Additionally, no correlations were observed between the parasite load in blood or
minimum length of infection with health status (S3 Fig).

Discussion
T. cruzi infects an extremely wide range of mammalian hosts, in addition to humans, and has
been studied primarily in experimentally infected rodents and occasionally other animals. A
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Fig 5. Phenotype of T cell subpopulation reflects the infected status of seropositive macaques. Peripheral blood samples were
stained for cell surface markers and analyzed by flow cytometry. (A) CD8+ and CD4+ T cell populations were subdivided into
naive, T central memory (Tcm) and T effector memory (Tem) subpopulations based on the expression of CD28 and CD95. Naiv
inf: naive T cells in infected macaques, Naiv non inf: naive T cells in non-infected macaques, Tem inf: T effector memory cells in
infected macaques, Tem non inf: T effector memory cells in non-infected macaques. (B) Early differentiated T cells
(CD45RA-CD28+CD27+) and fully differentiated T cells (CD45RA-CD28-CD27-) subpopulations were identified inside CD8+
and CD4+ T cell populations for non-infected (non inf; n = 5) and infected (infect; n = 62) macaques. Representative dot plots of
infected macaques are shown. Numbers in the dot plots indicate the percentage of events in the gate or quadrant out of the
displayed population. � = p<0.05, �� = p<0.01 by Mann Whitney test.
https://doi.org/10.1371/journal.pntd.0009141.g005
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Fig 6. T. cruzi parasites isolated from macaques belong to TcI and TcIV lineages. Parasite isolates were recovered
by hemoculture of red blood cell pellets after PBMC separation by ficoll-hypaque. (A) Representative electrophoresis
gel showing macaque isolate genotyping by PCR. TcI and TcIV lineages are identified by a 400 bp and 350 bp band,
respectively. Lanes 1 and 14: ladder; lanes 2–6 and 9–13: macaque isolates; lanes 7 and 8: TcI and TcIV reference
strains. Note the presence of a macaque with a mixed infection by both genotypes in lane 4. T cell (B) and antibody (C)
responses of the macaques infected with parasites belonging to TcIV and TcI lineages. Filled circles: TcIV (n = 6),
empty circles: TcI (n = 33), divided circle: isolate with mixed TcI and TcIV genotype (n = 1); �� = p<0.01; ns:
nonsignificant by Mann Whitney test.
https://doi.org/10.1371/journal.pntd.0009141.g006

number of case reports have documented naturally acquired T. cruzi in non-human primates
and a few additional studies have followed infection of small numbers of experimentally
infected non-human primates [30–32]. However, to our knowledge the current study is the
first to provide an in-depth study of a primate population naturally and chronically infected
with T. cruzi in a restricted geographical setting where both a characterization of the parasites
involved, and the immunological and clinical status of the hosts, have been examined. Indeed,
this level of examination of both parasite and host factors in a defined population of T. cruziinfected hosts has not been conducted in any species, including humans. Thus, this situation
of locally acquired, chronic infection in a large number of primates offered a unique research
opportunity.
Despite the fact that all animals in this study had acquired T. cruzi infection in this highly
restricted area, there is considerable parasitological and immunological variation in the infections. At least two genetic lineages of T. cruzi, TcI and TcIV, circulate in this setting, however,
neither the antibody response, the cardiac health of the macaques, or the parasite load in these
animals was associated with the parasite DTU. Furthermore, additional analyses of the parasite
lines obtained from these macaques demonstrated that isolates from different animals, but of
the same DTU, vary dramatically with respect to induced CD8+ T cell responses and virulence
in mice and in relative susceptibility to the anti-T. cruzi drug benznidazole. This result contrasts rather strikingly with the suggestions from other studies that the T. cruzi DTU determines critical factors about the course and severity of infection, immune response to T. cruzi,
and disease status [33,34]. It is noteworthy that none of these previous studies compared these
parameters among so many isolates collected from such a geographically restricted site as in
the current study. These results suggest at a minimum that the parasites of the same DTU and
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Fig 7. T. cruzi isolates from macaques display a wide phenotypic variation in mice. (A) T. cruzi DNA detection in tissues of C57BL/6 mice infected per
os (p.o.) with 106 metacyclic trypomastigotes from 8 macaque isolates at 120–150 days post-infection. (B) Survival curve of IFNg-KO mice infected
intraperitoneally with 106 metacyclic trypomastigotes from macaque T. cruzi isolates (n = 3 mice per isolate). (C) Frequency of CD8+ T cells in blood
specific for the immunodominant T. cruzi-TSKb20 epitope in C57BL/6 mice orally infected with macaque isolates. (D) Percentage of infected C57BL/6
mice cured after benznidazole treatment, determined by qPCR of skeletal muscle following immunosuppression (n = 4–5 per isolate). DTU: TcI (black),
TcIV (blue), or TcI+TcIV (red).
https://doi.org/10.1371/journal.pntd.0009141.g007

circulating in a narrowly restricted locale have a wide potential with respect to infection outcome. The results of this study indicate that one should expect similar or greater diversity
among parasites of the same DTU infecting humans, even in highly constrained geographic
settings.
Both of the major genetic lineages of T. cruzi previously obtained from hosts in North
America were also found in this macaque population and at least one animal had a mixed
genotype infection. This latter finding is not unique to this study [35] and indicates either
simultaneous transmission of 2 isolates in a single infection episode or more likely, the superinfection of an already infected host (as previously documented in other host species; [36,37].
The finding of a significant population of macaques with naturally acquired T. cruzi infection
in Texas reconfirms the existence of a highly active transmission cycle in the United States as
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Table 1. Parasitological and immunological parameters in macaques displaying cardiac anomalies.
Cardiac anomalya

a

positive

negative

qPCR (Par Eq/ml)

7.2 (0.01–55.5)

13.9 (0.02–228.0)

ELISpot (Counts/4x10e5 cells)

472.1 (42.2–911.0)

306.0 (50.8–554.8)

Serology (MFI)

19477.1 (17613.5–22772.0)

16484.9 (78.5–20321.5)

Hemocultureb

69.0% (9/13)

68.0% (26/38)

Length of infection (years)

6.3 (4.7–8.5)

6.4 (1.5–8.5)

Age (years)

11.7 (7.9–20.4)

12.0 (8.4–17.4)

Numbers indicates the average and the range in parenthesis.

b

For hemocultures the number indicates the percentage of positive and in parenthesis the number of positive
cultures out of the total.
https://doi.org/10.1371/journal.pntd.0009141.t001

well as the diversity and potentially high parasitemia- and disease- generating capacity of parasite isolates circulating in North America. These findings also reinforce the importance of
active surveillance for autochthonous cases in humans and particularly in domestic animals in
the USA.
In addition to parasite genetics, host genetic factors and the evolving immune responses in
infected hosts also contribute to the pattern of infection and disease in T. cruzi infection. The
health status and infection-related pathology in this group of macaques correlated with the
antibody response against a T. cruzi lysate (Fig 8). Considering the statistically significant association between the antibody responses and parasite levels in blood across the entire group of
macaques (Fig 2), it is tempting to link higher parasite load to poorer health status. However,
this direct association was not found (S3 Fig), nor were there statistically significant associations between blood parasite levels, cellular immune parameters and disease presentation.
Thus, as expected, the ability of hosts to rigorously restrict parasite levels and also to limit clinical disease is more complicated than can be divined from simply the parasite genotype or from
the measurement of numerous, but still quite limited, immune responses at a single point in
the infection and in a limited sample of animals with modest disease symptoms overall. These
results suggest that caution should also be exercised in drawing broad conclusions about the
specific roles of parasite genotypes and general host immune responses with respect to infection/disease outcomes, particularly when based on a relatively small numbers of samples collected over vast geographic areas.

Fig 8. Macaques with cardiac anomalies show a higher antibody response. Comparison of antibody (A) and T cell
responses (B) against T. cruzi lysate in seropositive macaques grouped in: animals displaying no symptoms (no
symptom; n = 28), poor general health condition (poor health; n = 9) or cardiac anomalies (cardiac anom; n = 13). �� =
p<0.01 by Mann Whitney test.
https://doi.org/10.1371/journal.pntd.0009141.g008
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This study also reemphasizes the limitations of available methods for assessing the T. cruzi
infection status in chronically exposed hosts. Prior exposure to T. cruzi infection can generally
be documented by serological assays. However, the scarcity of parasites in chronically infected
hosts as well as the immunological memory of that exposure, as demonstrated by the maintenance of sustained high antibody titers, makes determination of active infection–and therefore
assessment of spontaneous or drug-induced cure in T. cruzi infection–extremely difficult. This
situation is the major impediment to the wider use of current therapeutics and the assessment
of newly developed ones. PCR is considered to be among the most sensitive of techniques for
detection of active infection through the amplification of T. cruzi DNA from blood. In this
study, the combined analysis by serology, qPCR and hemoculture at 1–3 sampling points over
several months again confirmed the inadequacies of parasite detection methods in documenting active infection. Despite analysis of serial bleeds over time, qPCR failed to confirm the
infection in some known seropositive animals, including in animals in which parasites were
recovered by hemoculture. Thus, despite the powerful amplifying capabilities of qPCR, the low
level of parasites in the blood of chronically infected hosts make this technique inadequate for
dependable detection of infection or for assessment of infection cure–even when samples are
obtained serially over several months. This result strongly suggests that serial qPCR cannot be
used as single technique to confirm the infection in scenarios with low parasite levels in blood.
Recovery of parasites from the cultures of red blood cell pellets was surprisingly robust and
this protocol could be useful for obtaining parasite isolates from human subjects donating
PBMC for immunological studies. Even so, the detection of parasite DNA in hemocultures
without parasite growth and the lack of parasite isolation in some qPCR-positive animals
shows the limitations of this technique as well. A high positive proportion of hemoculture has
also been reported in particular cases of human infection [38]. Although the combination of
hemoculture and qPCR confirmed the presence of parasites in the blood of almost all the seropositive macaques studied, the failure of these parasitological techniques emphasizes again the
very low level of parasites in the chronic phase of T. cruzi infection and the stochastic nature of
the techniques to reveal infection, as well as the need to complement infection detection by
other methods, including immunological ones. In this regard, nearly all the macaques in the
study group displayed a strong antibody response against a parasite lysate and one or more
recombinant proteins assays by the multiplex assay, as well as a strong cellular response to T.
cruzi antigens. Additionally, the proportions of lymphocyte sub-populations reflected the
infected status of the animals although with a less strong correlation than has been reported in
human patients [24]. Interestingly, infected macaques did not display evidence of T cell
exhaustion as described in chronic human patients [39,40] possibly due to the relatively
shorter duration of infection of these macaques compared to chronically infected humans previously assessed. Similar findings have been reported in shorter-length human infections (in
children) [24].
Collectively, this study highlights the unique and high quality resource that primates with
naturally acquired T. cruzi infection in the southern of the USA offer for enhanced understanding of Chagas disease, and for further evaluation of techniques for such studies in
humans. Perhaps not surprisingly, the results also emphasize the biological complexities of this
infection, including host-parasite interactions, and reinforce the known high variation in
infection and disease potential of T. cruzi, even in a confined geographical space. In addition
to the obvious applications of this resource for e.g. testing of new therapeutics, captive nonhuman primate colonies housed outdoors in some parts of the southern USA provide a unique
opportunity to better understand the scope of genetic variation and evolution of T. cruzi, and
the frequency and consequences of genetic exchange in T. cruzi [41–43] under accessible,
highly controlled but otherwise natural infection conditions.
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Materials and methods
Ethics statement
The procedures for maintaining the macaques and blood sampling were approved (#1050MF)
by the Institutional Animal Care and Use Committee of the Texas Biomedical Research Institute, the host institution for the SNPRC. All procedures with mice were performed in conformance with protocols and standards approved by the University of Georgia Institutional
Animal Care and Use Committee under animal use protocol #A2012 05-003-R2.

Macaques, blood collection, and EKG
The macaques were housed in mixed-sex breeding groups in indoor/outdoor enclosures constructed of metal, concrete, and cyclone fencing at the SNPRC. The animals were permitted to
access both indoor and outdoor portions of the housing. Prior to the initial blood draw, the
housing was enclosed with a mesh and the doors were sealed to prevent entry of triatomines,
in order to ensure that reinfection did not occur after the initiation of the study. The enclosures contained enrichment devices. Blood was drawn from a saphenous vein after immobilization of the animal by intra-muscular injection of ketamine hydrochloride (10 mg/kg) and
valium (5mg), along with inhalation of isoflurane (1.5%). Twelve-lead EKG was performed on
the 51 qPCR positive macaques as described by Zabalgoitea et al. [44]. The animal facilities
were accredited by the Association for Assessment and Accreditation of Laboratory Animal
Care (AAALAC) International at the SNPRC.

Conventional serology
Serum samples collected from cynomolgus macaques over a period of 7 years were assessed by
conventional serology to identify individuals with antibodies against T. cruzi. Many of the
macaques were sampled and tested at two or more time points, enabling approximate dates of seroconversion from negative to positive to be established. Two assay methods were applied to each
sample at each time point. One method was an enzyme-linked immunosorbent assay (ELISA) that
detects IgG. Depending on availability at any given time point, the ELISA kits were obtained from
one or another of two sources: Bio-Manguinhos (Ministry of Health, Oswaldo Cruz Foundation,
Rio de Janeiro, Brazil), and IVD Research, Inc., Carlsbad, CA. The second method in the earlier
stages of screening was an indirect immuno-fluorescence assay (IFA) (Bio-Manguinhos) that
detects IgG and IgM. That method was replaced by an immuno-chromatographic assay, Chagas
Stat-Pak (Chembio Diagnostic Systems, Medford, NY), which detects antibodies directed against
several T. cruzi recombinant antigens. A sample was designated as positive only if both methods
gave positive results. There was a high concordance of results among all four of the assays.

qPCR for T. cruzi in macaque whole blood samples
Whole blood collected in Na2 EDTA tubes was mixed with an equal volume of lysis buffer
(6.0M guanidine, 0.2M EDTA, pH = 8.0), and the resultant GE-Blood mixture (GEB) was
incubated overnight at room temperature, followed by storage at 4˚C. High Pure PCR Template Preparation Kit (Roche Applied Science, Indianapolis, IN) was used to extract DNA
from 300 μl of GEB, to which had been added 200 pg of an internal amplification control
(IAC, a linearized pZErO plasmid containing a sequence of Arabidopsis thaliana; provided by
Dr. Alejandro Schijman), as described by Duffy et al. [45,46]. For construction of a standard
curve, non-infected monkey blood was spiked with cultured TcI epimastigotes to a concentration of 106 parasite eq/ml, mixed with lysis buffer and IAC, and extracted as described above.
Tenfold dilutions of this extract down to a concentration of 1 parasite eq/ml, followed by a
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2-fold dilution to a concentration of 0.5 parasite eq/ml, were used to construct the standard
curve for the quantification of parasites in each sample. Multiplex TaqMan real-time detection
of T. cruzi satellite DNA and IAC targets was performed using primer and probe sequences
and concentrations, and cycling parameters, in Duffy et al. [46]. Five μl of isolated DNA was
analyzed in triplicate using FastStart Universal Probe Master (Roche Applied Science, Indianapolis) in a final reaction volume of 20 μl. Amplifications were carried out in an ABI 7900HT
Sequence Detection System (Applied Biosystems, USA). The Tukey method [47] was used to
assess the triplicate IAC Ct values obtained from all the samples in each PCR run. If all three
replicates of a PCR sample had IAC outliers, as occurred for three of the samples, then the
sample was re-extracted and the qPCR procedure was repeated. For all other samples, values
with IAC outliers (if any) were discarded, and the mean of the remaining values was recorded
as the number of parasite eq/ml. This qPCR method was validated in consultation with Dr.
Alejandro Schijman’s laboratory (INGEBI-CONICET, Argentina) for precision estimates,
anticipated reportable range (105 to 0.5 parasite eq/mL), limit of quantification (LOQ) (2.46
parasite eq/mL), and limit of detection (LOD) (0.678 parasite eq/mL). For quality control
assessment, TcI epimastigotes cultured from one of the macaques were shipped to Dr. Schijman’s laboratory, where panels of spiked GEB samples were prepared and returned for blind
DNA isolation and qPCR.

Hemocultures
Following the removal of the ficoll (Sigma-Aldrich, MO) gradient fraction containing the
PBMC from 5 ml of whole blood, the remaining red blood cell-containing fraction was culture
in liver digested-neutralized tryptose (LDNT) medium at 27˚ C for up to 3 months. Cultures
were periodically screened under inverted microscope for motile parasites. Cultures with
detectable parasites were propagated in order to obtain and characterize T. cruzi isolates. Cultures with no visible parasites were subjected to standard PCR. Briefly, total DNA from hemocultures was extracted using a blood DNA extraction kit (Qiagen, MD) and amplified with
OneTaq 2x MasterMix solution (New England Biolabs, MA) mixed with T. cruzi specific primers for satellite DNA [48]. PCR products were run on 1.5% agarose gels and imaged in an
InGenius gel documentation system (SynGene, MD).

Parasite isolate genotyping
Epimastigote cultures of parasites isolated by hemoculture from the macaque blood samples
were lysed for 30 minutes at 50˚C in lysis buffer (150 mM NaCl, 100 mM EDTA, 100 ug/ml
proteinase K, 10 ug/ml RNase A, and 0.5% sodium sarcosinate, pH 8.0). DNA was then
extracted twice with phenol/chloroform and ethanol precipitated, then resuspended in 5 mM
Tris.Cl, pH 7.5. DNA sample integrity was checked by agarose gel electrophoresis. Discrete
typing unit (DTU) determinations were made following the method of Lewis, et al. [49]. Initial
discrimination between TcI and TcII—VI was performed by large subunit rRNA (LSU) PCR
and to further confirm the presence of TcI and TcIV a second PCR assay was performed to
amplify a portion of the mini-exon. TcI isolates amplify a 350 bp product in the mini-exon
PCR, whereas TcIV isolates produce a larger, 400 bp, product. PCR products from appropriate
DTU of control strains were included in all of the PCR assays to make clearer the sizes of the
amplified products in the test samples.

Cell surface phenotyping
Samples of 100 ul of whole peripheral blood collected in Na2EDTA were treated with red
blood cell lysis buffer and incubated with a mix of fluorescently labeled antibodies against cell
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surface proteins. Antibodies used were anti-CD8 PerCP 5.5 (clone RPA-T8), anti-CD4
APC-Cy7 (clone OKT4), anti-CD28 PE-Cy7 (clone CD28.2) from Biolegend, San Diego, CA;
anti-CD95 V450 (clone DX2), anti-CD45RA-Allophicocyanin (clone 5H9), anti-CD27-V450
(clone MT271) from BD Pharmingen, BD Biosciences, San Jose, CA; and anti-CCR7-Allophicocyanin (clone 150503) from R&D Systems, Minneapolis, MN. Data from un-fixed samples
were acquired in a Beckman Coulter CyAn ADP cytometer and analyzed using the software
FlowJo v10.2 (FlowJo, Ashland, OR).

T. cruzi amastigote/trypomastigote lysate
Brazil strain extracellular amastigotes were obtained from trypomastigote cultures induced
overnight in pH 5 RPMI 1640 media supplemented with 10% fetal calf serum and 10 mM
phosphate citrate buffer. A mix of amastigotes and trypomastigotes was subjected to freeze/
thaw cycles followed by sonication. Cellular debris was removed by centrifugation at 12,000
rpm and the supernatant was collected. After filter sterilization, the total protein concentration
was determined by Bradford assay.

Serology testing with recombinant protein multiplex bioassay
Macaque plasma reactivities against 9 recombinant T. cruzi proteins and parasite lysate were
tested in a multiplex assay previously described for testing human and dog serum samples
[20,22]. Briefly, macaque plasma was diluted 1:500 and incubated with a pool of the recombinant T. cruzi proteins attached to addressable Liquichip Ni-NTA beads (Qiagen, CA) and T.
cruzi amastigote/trypomastigote lysate coupled to Carboxy-Ni-NTA beads (Qiagen Inc). Antibody binding was detected with goat anti-human IgG conjugated to phycoerythrin and quantified on a Bio-Plex Suspension Array System (Bio-Rad, Hercules, CA, USA). Weighted median
fluorescence intensity (MFI) for samples in duplicate was calculated and the ratio of the specific MFI for each antigen versus a negative control (green fluorescent protein) was estimated
for each antigen.

Interferon-gamma ELISPOT assay
Peripheral blood mononuclear cells (PBMC) isolated by Ficoll gradient were seeded at 4 x 105
cells/mL and stimulated with 10 mg/mL T. cruzi lysate (Brazil strain), cytomegalovirus peptides or 10 ng/mL phorbol-12-myristate-acetate (PMA) and 500 ng/mL Ionomycin for 16 h at
37˚C in a 5% CO2 environment; PBMC incubated with complete RPMI media were used as
non-stimulated controls. Spot forming cells were automatically enumerated using an ImmunoSpot analyzer (CTL, Cleveland, Ohio). The mean number of spots in triplicate wells was
obtained for each condition. The number of specific IFN-γ-secreting T cells was calculated by
subtracting the value of the wells containing media alone from the lysate/peptide-stimulated
spot count.

Mice infections with macaque isolates
C57BL/6 and B6.129S7-Ifngtm1Ts/J IFNγ cytokine knockout mice (IFNg-KO) were originally
purchased from Charles River Laboratories and The Jackson Laboratory respectively and
propagated in the University of Georgia animal facility in microisolator cages under specific
pathogen-free conditions. Metacyclic trypomastigotes were differentiated from epimastigote
cultures using triatomine artificial urine (TAU) and TAU3AAG and purified by incubating
overnight with non-heat inactivated fetal bovine serum as described previously [50,51]. Mice
were infected intraperitoneally (i.p.) or per os (p.o.) with 106 metacyclic trypomastigotes and
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euthanized between 120–150 days post- infection to collect skeletal muscle, cardiac muscle,
and adipose tissues for quantitative Real-Time PCR (RT-PCR) analysis [52].

Parasite quantification in infected mouse tissues by Quantitative RealTime PCR
Parasite load was quantified based on the protocol described previously [52]. Briefly, tissues
were lysed using tissue lysis buffer consisting of 10 mM Tris–HCl (pH 7.6), 0.1M NaCl, 10
mM EDTA, 0.5% SDS, and 300g of proteinase K/ml. Samples were then heated for 2 h at 55˚C,
and extracted with phenol:chloroform:isoamyl alcohol (Fisher Scientific). Cold ethanol was
used to wash and precipitate the DNA along with sodium acetate. Each PCR reaction contained 50 ng of genomic DNA, 0.5 μM TcSAT30_F (5’-GGCGGATCGTTTTCGAG), 0.5 μM
TcSAT179_R (5’-AAGCGGATAGTTCAGGG), iQ SYBR Green Supermix (Bio-Rad), and
nuclease free water (Ambion) to 20 μl. Quantitative PCR was performed using CFX96 Touch
Real-Time PCR detection system (Bio-Rad) and analyzed using the Bio-Rad CFX Manager
software (Bio-Rad).

Detection of T. cruzi specific CD8+ T cell response in mice
Mouse peripheral blood was obtained by retro-orbital venipuncture, collected in sodium citrate solution, washed, and stained as previously described [53]. Briefly, whole blood was incubated with red blood cell lysis buffer for 5–10 minutes and washed twice with PAB (1x
phosphate-buffered saline, 1% bovine serum albumin, and 0.1% sodium azide) solution. Cells
were probed with MHC-TSKB20 peptide tetramer complexes conjugated to Brilliant Violet
421 fluorophore and the following labeled antibodies: anti-CD44 PerCP-Cy5.5 (eBioscience,
CA), anti-KLRG1 PE-Cyanine7 (eBioscience, CA), anti-CD8a FITC (Accurate Chemical), and
anti-CD127 PE (eBioscience, CA). Cells were also stained with anti-CD4 APC-ef780
(eBioscience, CA), which was used as an exclusion channel. A minimum of 500,000 events
were collected using a Cyan ADP flow cytometer (Beckman Coulter, FL) and analyzed with
FlowJo Version X software (FlowJo, Ashland, OR). MHC-peptide complexes were provided as
biotinylated monomers and/or fluorophore-conjugated tetramers by the NIH Tetramer Core
Facility at Emory University (Atlanta, GA) and used for identification of CD8+ T cells specific
to the TSKB20 (ANYKFTLV/Kb) epitope as described previously [26].

Sensitivity of macaque isolates to benznidazole treatment
Benznidazole (LAFEPE Medicamentos, Brazil) was prepared by pulverization of one tablet
containing 100 mg of the active principle, followed by suspension in distilled water. Mice were
drug treated via oral gavage with at 100 mg/kg of body weight once every 5 days for 60 days as
described previously [27]. Two to three weeks after the end of treatment, mice were immunosuppressed with cyclophosphamide (200 mg/kg/day) injected i.p. at 2–3 days interval for a
total of four doses. Survival and parasitemia were monitored daily in untreated controls beginning 10 days after the start of cyclophosphamide treatment. After parasite detection in blood
of untreated controls, all mice were euthanized and tissue samples were collected for parasite
load determination by RT-PCR.

Statistical analysis
Statistical analysis by nonparametric Mann-Whitney test and the nonparametric Spearman
correlation coefficient (rs) were performed using the GraphPad Prism 9.0 software. Differences between 2 groups were considered significant at P <0.05.
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Supporting information
S1 Fig. Macaques in the study had been infected at least for an average duration of 6.5
years. Male (n = 19) and female (n = 31) macaques in the study had similar ages and displayed
comparable minimum length of infection ranging from 1.5 to 8.5 years.
(PDF)
S2 Fig. Parasite levels in blood and minimum length of infection were similar in macaques
infected with either TcI or TcIV. Parasite load in blood detected by qPCR (A) and minimum
length of infection (B) in macaques infected with T. cruzi isolates belonging to lineages TcI
(n = 33 in A; n = 27 in B) and TcIV (n = 7). ns: non-significant by Mann Whitney test.
(PDF)
S3 Fig. Health condition of seropositive macaques does not correlate with parasite load or
minimum length of infection. Parasite level in blood determined by qPCR (A) and minimum
length of infection (B) in animals displaying no symptoms (no symptom; n = 28), poor general
health condition (poor health; n = 9) or cardiac anomalies (cardiac anom; n = 13). ns: non-significant by Mann Whitney test.
(PDF)
S1 Data. Data set containing all numerical values used to generate Figure panels.
(XLSX)
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